Journal of Basic and Clinical Pharmacy expect the highest ethical standards from their authors, reviewers and editors while conducting research, submitting papers and throughout the peer-review process. Journal of Basic and Clinical Pharmacy follows single-blind peer review process.
Redundant or duplicate publication
A publication that overlaps or relates substantially with any article that is already published, in press, or under consideration/submission it is considered as Duplicate or redundant publication. (International Committee of the Medical Editors http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html).
Duplicate or redundant submission is identical manuscript (or having the similar data) that is submitted to various journals at the same time. International copyright laws, ethical conducts, and cost effective use of resourceensure originality of the manuscript submitted. (International Council of the Medical Editors. http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html)
Material submitted must be original and should not have published or submitted elsewhere while under consideration for publication. According to the APA code of ethics (APA Publication Manual, 2010) duplicate publication is violation and will lead to prompt rejection of the submitted manuscript.
In case of any doubts, author should seek advice from the editorial board member in handling their manuscript. If author is re-using a figure published elsewhere or that has been copyrighted then the author must get prior approval from the previous publisher or the copyright holder for the figure to be re-published. In case, author is unaware of the copyright issues and the material has been published, the author must submit a duplicate material for submission by acknowledging the source of the information, so that the ethical violation can be corrected.
Conflicts of interest
In order to maintain transparency and help readers to form their own judgements of potential bias, authors should declare any competing financial interests related to the work that has been described or presented.
During the submission, every author should reveal the financial interests or collaborations if any, that may raise conflict or bias directly or indirectly in the submitted work including conclusions, opinions given or implications, or any other sources of funding for related direct or indirect academic competition.
However, in case of manuscript acceptance, the information related to Conflict of Interest should be mentioned in a published statement.
Permissions to reproduce previously published material
Permission is essential to reproduce material from the copyright holder. Articles cannot be directly published without these permissions.
Withdrawal of articles
The journal is vowed to ensure the originality and authenticity of all articles published in it. In cases where the editorial team observes any technical or ethical discrepancy in an article viz. multiple submissions of the data, plagiarism, deceitful manipulation of data, spurious authorship claims, it may be withdrawn. The option of withdrawal mainly pertains to the articles that are currently in Press. Such articles are yet to be published formally and thus lack volume/issue/page information. Immediately after the article is withdrawn, the entire content of the article is removed from the journal website and a withdrawal notice is placed instead.
© Journal of Basic and Clinical Pharmacy
Online since 10 September, 2012 -